← Back to Search

Amygdala recording and stimulation using Neuropace RNS for Panic Disorder

N/A
Waitlist Available
Led By Mahendra Bhati, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 days
Awards & highlights

Study Summary

This trial will test the feasibility of a new procedure to study the human amygdala, as well as the effects of stimulation on fear and reward processing.

Eligible Conditions
  • Panic Disorder
  • Post-Traumatic Stress Disorder
  • Anxiety

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ECoG (ElectroCorticoGraphy) amplitude changes
Electrocorticogram
EEG(electroencephalography) amplitude changes
+1 more
Secondary outcome measures
Electrophysiological changes in EDA
Electrophysiological changes in EMG

Trial Design

1Treatment groups
Experimental Treatment
Group I: Neurophysiological recording and stimulation of amygdalaExperimental Treatment2 Interventions
Recording and stimulation of amygdala using Neuropace RNS devices at certain points through out the behavioral tasks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral tasks
2009
N/A
~1300
Amygdala recording and stimulation using Neuropace RNS
2019
N/A
~30

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,676 Total Patients Enrolled
29 Trials studying Panic Disorder
7,254 Patients Enrolled for Panic Disorder
Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,327 Total Patients Enrolled
1 Trials studying Panic Disorder
136 Patients Enrolled for Panic Disorder
Mahendra Bhati, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
795 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this experiment currently underway?

"The clinicaltrial.gov website informs that this medical trial is no longer accepting candidates, having posted initially on April 24th 2019 and last modified September 20th 2021. Nevertheless, 359 other studies are actively seeking patients at present."

Answered by AI

Are individuals 55 years and older being enrolled in this experimental program?

"Candidates wishing to take part in this trial must fall within the 18-65 age bracket. For those younger than 18, there are 48 studies available and 261 for individuals over 65 years of age."

Answered by AI

Can I be part of this experiment?

"To be eligible for inclusion in this trial, participants must suffer from panic attacks and have an age between 18 to 65. There are 30 open slots available overall."

Answered by AI
Recent research and studies
~4 spots leftby Apr 2025